Paul Burton - Aug 5, 2021 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
Chief Medical Officer
Signature
/s/ Brian Sandstrom, as Attorney-in-Fact
Stock symbol
MRNA
Transactions as of
Aug 5, 2021
Transactions value $
$0
Form type
4
Date filed
8/9/2021, 04:29 PM
Previous filing
Jul 6, 2021
Next filing
Mar 3, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MRNA Stock Option (Right to Buy) 15K Aug 5, 2021 Common Stock 15K $416.26 Direct F1
holding MRNA Restricted Stock Units 6.44K Aug 5, 2021 Common Stock 6.44K $0.00 Direct F2
holding MRNA Restricted Stock Units 3.22K Aug 5, 2021 Common Stock 3.22K $0.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option will vest and become exercisable on August 5, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F2 25% of the shares subject to this restricted stock unit award will vest on August 5, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F3 The shares subject to this restricted stock unit award will vest in full on August 5, 2024, subject to the recipient's continued service.